Literature DB >> 512939

Potent stimulation of the avian exocrine pancreas by porcine and chicken vasoactive intestinal peptide.

R Dimaline, G J Dockray.   

Abstract

1. The actions of chicken and porcine secretins and vasoactive intestinal peptides (VIPs) were compared on the rate of flow and rate of protein secretion from the exocrine pancreas in urethane anaesthetized turkeys and rats. 2. Chicken VIP was about twice as potent as porcine VIP and 100-150 times as potent as chicken and porcine secretins in stimulating the flow of pancreatic juice in the turkey. 3. Porcine secretin was a strong stimulant of the flow of pancreatic juice in the rat, but chicken secretin and the two VIPs were only active in doses 20-50 times higher than those of porcine secretin. 4. Neither the two VIPs nor the two secretins significantly stimulated the rate of pancreatic protein secretion in the turkey or rat. 5. In the turkey I.V. infusion of graded doses of chicken VIP produced graded increases in the flow of pancreatic juice; in the presence of an infusion of a low dose of CCK8 the flow of juice secreted in response to the highest dose of chicken VIP was significantly lower compared with the infusion of VIP alone, and responses to the other doses of VIP were lower but not significantly so. The infusion of chicken secretin reduced the flow of juice in response to infusions of chicken VIP, but the differences were not significant. There was no significant difference in either the rate of flow, or rate of protein secretion from the turkey pancreas in response to an infusion of chicken secretin and CCK8, compared with CCK8 alone. 6. The results cast doubt on the importance of secretin for regulation of the avian pancreas, and suggest instead that VIP might have a physiological role in regulating the flow of pancreatic juice in birds.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 512939      PMCID: PMC1280549          DOI: 10.1113/jphysiol.1979.sp012922

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  21 in total

1.  Vasoactive intestinal peptide: a secretin-like partial agonist for pancreatic secretion in man.

Authors:  S Domschke; W Domschke; W Rösch; S J Konturek; W Sprügel; P Mitznegg; E Wünsch; L Demling
Journal:  Gastroenterology       Date:  1977-09       Impact factor: 22.682

2.  Comparison of the actions of porcine secretin and extracts of chicken duodenum on pancreatic exocrine secretion in the cat and turkey.

Authors:  G J Dockray
Journal:  J Physiol       Date:  1975-01       Impact factor: 5.182

3.  Potentiation of secretin stimulation of the pancreas.

Authors:  J C Brown; A A Harper; T Scratcherd
Journal:  J Physiol       Date:  1967-06       Impact factor: 5.182

4.  Structure of the porcine vasoactive intestinal octacosapeptide. The amino-acid sequence. Use of kallikrein in its determination.

Authors:  V Mutt; S I Said
Journal:  Eur J Biochem       Date:  1974-03-01

5.  Vasoactive intestinal peptide (VIP) cells in the pancrease and gastro-intestinal mucosa. An immunohistochemical and ultrastructural study.

Authors:  R Buffa; C Capella; E Solcia; B Frigerio; S I Said
Journal:  Histochemistry       Date:  1977-01-24

6.  Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons.

Authors:  L I Larsson; J Fahrenkrug; O Schaffalitzky De Muckadell; F Sundler; R Håkanson; J R Rehfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

7.  Innervation of the pancreas by vasoactive intestinal polypeptide (VIP) immunoreactive nerves.

Authors:  L I Larsson; J Fahrenkrug; J J Holst; O B Schaffalitzky de Muckadell
Journal:  Life Sci       Date:  1978-03       Impact factor: 5.037

8.  Plasma secretin concentration in man: effect of intraduodenal glucose, fat, amino acids, ethanol, HCl, or ingestion of a meal.

Authors:  J Fahrenkrug; O B Schaffalitzky de Muckadell
Journal:  Eur J Clin Invest       Date:  1977-06       Impact factor: 4.686

9.  Multiple immunoreactive forms of vasoactive intestinal peptide in human colonic mucosa.

Authors:  R Dimaline; G J Dockray
Journal:  Gastroenterology       Date:  1978-09       Impact factor: 22.682

10.  The action of scretin, cholecystokinin-pancreozymin and caerulein on pancreatic secretion in the rat.

Authors:  G J Dockray
Journal:  J Physiol       Date:  1972-09       Impact factor: 5.182

View more
  7 in total

1.  Vasoactive intestinal polypeptide-like immunoreactivity in nerves of the pancreatic islet of the teleost fish, Gillichthys mirabilis.

Authors:  S Van Noorden; G J Patent
Journal:  Cell Tissue Res       Date:  1980       Impact factor: 5.249

2.  The distribution and cellular origin of vasoactive intestinal polypeptide in the avian gastrointestinal tract and pancreas.

Authors:  C Vaillant; R Dimaline; G J Dockray
Journal:  Cell Tissue Res       Date:  1980       Impact factor: 5.249

3.  Enhancement by atropine of the pancreatic exocrine secretions evoked by vagal stimulation in the pithed rat.

Authors:  J Barrett; J J McDougall; J D Morrison
Journal:  J Physiol       Date:  1993-09       Impact factor: 5.182

4.  Factors influencing the intestinal phase of pancreatic exocrine secretion in the turkey.

Authors:  S Satoh; M Furuse; J Okumura
Journal:  Experientia       Date:  1995-03-15

5.  Cerulein-induced acute pancreatitis in the rat. Study of pancreatic secretion and plasma VIP and secretin levels.

Authors:  M A Manso; J I San Román; I de Dios; L J García; M A López
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

6.  Duck pancreatic acinar cell as a unique model for independent cholinergic stimulation-secretion coupling.

Authors:  Bi Jue Wang; Hui Yuan Liang; Zong Jie Cui
Journal:  Cell Mol Neurobiol       Date:  2009-04-16       Impact factor: 5.046

7.  Effect of synthetic chicken vasoactive intestinal peptide on pancreatic blood flow and on exocrine and endocrine secretions of the pancreas in dogs.

Authors:  K Inoue; T Kawano; K Shima; T Kim; T Suzuki; T Tobe; M Takeyama; H Yajima
Journal:  Dig Dis Sci       Date:  1983-08       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.